The expression of selenium-binding protein 1 is decreased in uterine leiomyoma

Diagnostic Pathology

Volumn 5, Issue 1, 2010, Pages

  Zhang, Peng ^a   Zhang, Cunxian ^a   Wang, Xudong ^a   Liu, Fang ^a   Sung, C James ^a   Quddus, M Ruhul ^a   Lawrence, W Dwayne ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENBP1 PROTEIN, HUMAN; SELENIUM BINDING PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CHEMISTRY; DOWN REGULATION; FEMALE; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MIDDLE AGED; PATHOLOGY; TUMOR VOLUME; UTERUS CANCER; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; DOWN-REGULATION; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MIDDLE AGED; SELENIUM-BINDING PROTEINS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 78649801179     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-5-80     Document Type: Article

References (35)

1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990, 94:435-438.
2. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003, 188:100-107. 10.1067/mob.2003.99, 12548202.
3. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003, 111:1037-1054. 10.1289/ehp.5787, 1241553, 12826476.
4. Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol 2000, 95:764-769. 10.1016/S0029-7844(99)00605-5, 10775744.
5. Haney AF. Clinical decision making regarding leiomyomata: what we need in the next millenium. Environ Health Perspect 2000, 108(suppl 5):835-839. 10.2307/3454315, 11035991.
6. Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 2002, 99:229-234. 10.1016/S0029-7844(01)01723-9, 11814502.
7. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994, 83:549-555. 10.1097/00006250-199404000-00011, 8134065.
8. Templeman C, Marshall SF, Clarke CA, Henderson KD, Largent J, Neuhausen S, Reynolds P, Ursin G, Berstein L. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Steril 2009, 92:1436-1446. 10.1016/j.fertnstert.2008.08.074, 2765807, 19019355.
9. Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) 1986, 293:359-362. 10.1136/bmj.293.6543.359, 1341047, 3730804.
10. Samadi AR, Lee NC, Flanders WD, Boring JR, Parris EB. Risk factors for self-reported uterine fibroids: a case-control study. Am J Public Health 1996, 86:858-862. 10.2105/AJPH.86.6.858, 1380408, 8659663.
11. Marshall LM, Spiegelman D, Goldman MB, Manson JE, Colditz GA, Barbieri RL, Stampfer MJ, Hunter D. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 1998, 70:432-439. 10.1016/S0015-0282(98)00208-8, 9757871.
12. Marshall LM, Speigelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997, 90:967-973. 10.1016/S0029-7844(97)00534-6, 9397113.
13. Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981, 36:433-445.
14. Richards PA, Tiltman AJ. Anatomical variation of the oestrogen receptor in the non-neoplastic myometrium of fibromyomatous uteri. Virchows Arch 1996, 428:347-351. 10.1007/BF00202201, 8797938.
15. Townsend DE, Sparkes RS, Baluda MC, McClelland G. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis of glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 1970, 107:1168-1173.
16. Mashall RD, Fejzo ML, Friedman AJ, Mitchner N, Nowak RA, Rein MS, Morton CC, Sklar J. Analysis of androgen rectpror DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer 1994, 11:1-6. 10.1002/gcc.2870110102, 7529041.
17. Zhang P, Zhang C, Hao J, Sung CJ, Quddus MR, Steinhoff MM, Lawrence WD. Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma. Hum Pathol 2006, 37:1350-1356. 10.1016/j.humpath.2006.05.005, 16949924.
18. Hashimoto K, Azuma C, kamiura S, Kimura T, Nobunaga T, Kanai T, Sawada M, Noguchi S, Saji F. Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest 1995, 40:204-208. 10.1159/000292336, 8529956.
19. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996, 276:1957-1963.
20. Whanger PD. Selenium and its relationship to cancer: an update. Br J Nutr 2004, 91:11-28. 10.1079/BJN20031015, 14748935.
21. Rayman MP. The importance of selenium to human health. Lancet 2000, 356:233-241. 10.1016/S0140-6736(00)02490-9, 10963212.
22. Chang PW, Tsui SK, Liew C, Lee CC, Waye MM, Fung KP. Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. J Cell Biochem 1997, 64:217-224. 10.1002/(SICI)1097-4644(199702)64:2<217::AID-JCB5>3.0.CO;2-#, 9027582.
23. Yang M, Sytkowski AJ. Differential expression and androgen regulation of the human selenium-binding protein gene hSP56 in prostate cancer cells. Cancer Res 1998, 58:3150-3153.
24. Chen G, Wang H, Miller CT, Thomas DG, Gharib TG, Misek DE, Giordano TJ, Orringer MB, Hanash SM, Beer DG. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J Pathol 2004, 202:321-329. 10.1002/path.1524, 14991897.
25. Kim H, Kang HJ, You KT, Kim SH, Lee KY, Kim TI, Kim C, Song SY, Kim HJ, Lee C, Kim H. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 2006, 6:3466-3476. 10.1002/pmic.200500629, 16645984.
26. Zhang C, Wang YE, Zhang P, Liu F, Sung CJ, Steinhoff MM, Quddus MR, Lawrence WD. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma. Hum Pathol 2010, 41:255-261. 10.1016/j.humpath.2009.07.019, 19896693.
27. Pumford NR, Martin BM, Hinson JA. A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein. Biochem Biophys Res Commun 1992, 182:1348-1355. 10.1016/0006-291X(92)91881-P, 1540179.
28. Giometti CS, Liang X, Tollaksen SL, Wall DB, Lubman DM, Subbarao V, Rao MS. Mouse liver selenium-binding protein decreased in abundance by peroxisome proliferators. Electrophoresis 2000, 21:2162-2169. 10.1002/1522-2683(20000601)21:11<2162::AID-ELPS2162>3.0.CO;2-S, 10892727.
29. Porat A, Sagiv Y, Elazar Z. A 56-kDa selenium-binding protein participates in intra-Golgi protein transport. J Biol Chem 2000, 275:14457-14465. 10.1074/jbc.275.19.14457, 10799528.
30. Pohl NM, Tong C, Fang W, Bi X, Li T, Yang W. Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts. PloS One 2009, 4:e7774. 10.1371/journal.pone.0007774, 2774949, 19924303.
31. Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, Onate SA, Gao AC. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells. Cancer Res 2005, 65:3487-3492.
32. Combs GF, Gray WP. Chemopreventive agents: selenium. Pharmacol Ther 1998, 79:179-192. 10.1016/S0163-7258(98)00014-X, 9776375.
33. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr 1998, 128:1845-1854.
34. Medina D. Mechanisms of selenium inhibition of tumorigenesis. Adv Exp Med Biol 1986, 206:465-472.
35. Huang KC, Park DC, Ng SK, Lee JY, Ni X, Ng WC, Bandera CA, Welch WR, Berkowitz RS, Mok SC, Ng SW. Selenium binding protein 1 in ovarian cancer. Int J Cancer 2006, 118:2433-2440. 10.1002/ijc.21671, 16380993.